ACOG 2025: Menopause and Vasomotor Symptoms Preview

Optimizing Treatment of Vasomotor Symptoms: It's Not One-Size-Fits-All

May 16, 2025, at 10:45AM CT

Vasomotor symptoms can significantly impact quality of life for many women, but treament options are evolving. There are now a multitude of hormonal regimes and doses, as well as a growing number of nonhormonal options. Reviewing case-based scenarios, this session will review best practices for tailoring treatments for disruptive vasomotor symptoms.

Speakers

Erin A. Keyser, MD
San Antonio Uniformed Services Health Education Consortium, San Antonio, TX.

Michelle Jacobson, MD
University of Toronto, Toronto, Canada.

Product Theater Lunch: Learn About Nonhormonal FDA-Approved Treatment for Moderate to Severe Vasomotor Symptoms Due to Menopause

May 16, 2025, at 12:00PM CT

In this session, we will review an FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause, including indication, mechanism of action, and clinical safety and efficacy.

Speaker

Genevieve Neal-Perry, MD, PhD;
Chapel Hill, NC.

Supported by Astellas Pharma US, Inc.

The Hale Lecture: Menopause Management: Understanding the Physiology and Applying the Evidence to Provide the Best in Patient-Centered Care

May 16, 2025, at 4:15PM CT

This session will address the physiology of perimenopause and the menopausal transition. It will address recognition of both common and atypical presentations of the menopause transition while facilitating a comprehensive understanding of evidence-based non-pharmacologic and pharmacologic treatment options for vasomotor symptoms. Lastly, the session will also provide helpful guidance on how and where to access additional evidence-based resources for menopause management.

Speaker

Jill H. Liss, MD
Aurora, Colorado

Product Theater Reception: Vasomotor Symptoms (VMS): Physiology and Significance

May 16, 2025, at 5:30PM

• Discuss physiology, incidence, and impact of Vasomotor Symptoms on midlife health
• Review the HPO axis and introduce developing scientific understandings of the neurophysiology of menopausal VMS
• Present a counseling approach for discussing VMS with patients
• Review principles of patient-centered counseling using the SHARE model (Seek, Help, Assess, Reach, Evaluate)

Speaker

Lauren F. Streicher, MD
Chicago, IL.

Supported by Bayer Medical Affairs

From Hot Flashes to Sleepless Nights: Evolving Strategies for Navigating the Full Range of Menopause Symptoms

May 17, 2025, at 7:00PM CT

The treatment landscape for symptoms associated with menopause is expanding. Evolving evidence supports the central role of the hypothalamic kisspeptin/neurokinin B/dynorphin (KNDy) system on vasomotor symptoms (VMS) and sleep and mood disturbances associated with menopause. In this live, interactive, newsroom-style symposium, expert faculty will discuss the latest evidence and data regarding treatment options, the role of emerging treatments to address unmet needs in managing the spectrum of symptoms, improving patient quality of life, and how to effectively engage patients in the shared decision-making process to enhance clinical dialogue and patient outcomes.

Speakers

Stephanie S. Faubion, MD, MBA
Rochester, MN

Diana Bitner, MD
Spring Lake, MI

Mary Jane Minkin, MD
Guilford, CT

A. Patel,
Atlanta, GA

This activity has been supported by an independent educational grant from Bayer.

Finding New Ways to Beat the Heat: Novel Therapies for Menopausal Vasomotor Symptoms

May 18, 2025, at 6:15 AM CT

It's undeniably the HOTTEST women's health topic of 2025—MENOPAUSE! Have breakfast with Dr. Stephanie Faubion and Dr. Jewel Kling and hear their lively discussion and debate about best practices for the management of the vasomotor symptoms of menopause. We'll also address all of your burning clinical conundrums, so come prepared with your questions for our experts!

Speakers

Stephanie S. Faubion, MD, MBA
Rochester, MN.

Juliana (Jewel) M. Kling, MD, MPH
New York, NY

This activity is supported by an educational grant from Astellas.